| Log in
research-1029340_640.jpg

Laurus Labs recorded steep decline in revenue growth & net profit in FY15

07 June, 2016

Vishakhapatnam-based drug ingredients maker Laurus Labs, which has true-blue private equity firm Warburg Pincus on board as an investor and is now planning an initial public offer, ....

To read the Full Story

Covering India’s Investment Ecosystem

subscribe

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Warburg Pincus picks stake worth $92M in Laurus Labs, Fidelity PE part exits

Warburg Pincus picks stake worth $92M in Laurus Labs, Fidelity PE part exits

Jasleen Kaur Batra 3 years ago
Vishakhapatnam-based drug ingredients maker Laurus Labs has said global private...
Laurus Labs files for IPO; Warburg Pincus, Eight Roads to part-exit

Laurus Labs files for IPO; Warburg Pincus, Eight Roads to part-exit

Joseph Rai 1 year ago
Laurus Labs Pvt. Ltd has filed its draft red herring prospectus (DRHP) with the...
Warburg Pincus-backed Laurus Labs eyes $660 mn valuation in IPO

Warburg Pincus-backed Laurus Labs eyes $660 mn valuation in IPO

Ankit Doshi 10 months ago
Hyderabad-based drugmaker Laurus Labs Ltd is seeking a valuation of as much as...
No Comments

Laurus Labs recorded steep decline in revenue growth & net profit in FY15

Powered by WordPress.com VIP